 Risk Assessment
"Risk Assessment" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)
| Descriptor ID |
D018570
|
| MeSH Number(s) |
E05.318.740.600.800.715 N04.452.871.715 N05.715.360.750.625.700.690 N06.850.505.715 N06.850.520.830.600.800.715
|
| Concept/Terms |
Risk Assessment- Risk Assessment
- Assessments, Risk
- Risk Assessments
- Assessment, Risk
Benefit-Risk Assessment- Benefit-Risk Assessment
- Assessment, Benefit-Risk
- Assessments, Benefit-Risk
- Benefit Risk Assessment
- Benefit-Risk Assessments
- Risk-Benefit Assessment
- Assessment, Risk-Benefit
- Assessments, Risk-Benefit
- Risk Benefit Assessment
- Risk-Benefit Assessments
|
Below are MeSH descriptors whose meaning is more general than "Risk Assessment".
Below are MeSH descriptors whose meaning is more specific than "Risk Assessment".
This graph shows the total number of publications written about "Risk Assessment" by people in this website by year, and whether "Risk Assessment" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1983 | 0 | 1 | 1 | | 1985 | 0 | 1 | 1 | | 1988 | 0 | 1 | 1 | | 1989 | 1 | 0 | 1 | | 1990 | 2 | 0 | 2 | | 1991 | 0 | 1 | 1 | | 1992 | 1 | 0 | 1 | | 1993 | 0 | 2 | 2 | | 1994 | 1 | 2 | 3 | | 1995 | 1 | 5 | 6 | | 1996 | 1 | 10 | 11 | | 1997 | 1 | 9 | 10 | | 1998 | 0 | 6 | 6 | | 1999 | 0 | 10 | 10 | | 2000 | 1 | 12 | 13 | | 2001 | 0 | 21 | 21 | | 2002 | 1 | 24 | 25 | | 2003 | 2 | 41 | 43 | | 2004 | 3 | 41 | 44 | | 2005 | 5 | 47 | 52 | | 2006 | 6 | 65 | 71 | | 2007 | 6 | 65 | 71 | | 2008 | 9 | 84 | 93 | | 2009 | 4 | 70 | 74 | | 2010 | 9 | 84 | 93 | | 2011 | 6 | 89 | 95 | | 2012 | 9 | 86 | 95 | | 2013 | 5 | 58 | 63 | | 2014 | 11 | 76 | 87 | | 2015 | 7 | 83 | 90 | | 2016 | 10 | 86 | 96 | | 2017 | 9 | 92 | 101 | | 2018 | 23 | 91 | 114 | | 2019 | 17 | 91 | 108 | | 2020 | 5 | 66 | 71 | | 2021 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Risk Assessment" by people in Profiles.
-
Meltzer DO, Best TJ, Zhang H, Vokes T, Arora VM, Solway J. Association of Vitamin D Levels, Race/Ethnicity, and Clinical Characteristics With COVID-19 Test Results. JAMA Netw Open. 2021 03 01; 4(3):e214117.
-
Potts MB, Abdalla RN, Golnari P, Sukumaran M, Palmer AH, Hurley MC, Shaibani A, Jahromi BS, Ansari SA. Analysis of Mechanical Thrombectomy for Acute Ischemic Stroke on Nights and Weekends Versus Weekdays at Comprehensive Stroke Centers. J Stroke Cerebrovasc Dis. 2021 Apr; 30(4):105632.
-
Loggini A, Ammar FE, Awad IA, Lazaridis C, Kramer CL, Kordeck C, McKoy C, Goldenberg FD, Mansour A. Temporal Evolution and Outcomes of Non-Traumatic Intracerebral Hemorrhage in Hospitalized Patients. J Stroke Cerebrovasc Dis. 2021 Mar; 30(3):105584.
-
Menacho ST, Grandhi R, Delic A, Anadani M, Ziai WC, Awad IA, Hanley DF, de Havenon A. Impact of Intracranial Pressure Monitor-Guided Therapy on Neurologic Outcome After Spontaneous Nontraumatic Intracranial Hemorrhage. J Stroke Cerebrovasc Dis. 2021 Mar; 30(3):105540.
-
Hawkins M, Bhatia S, Henderson TO, Nathan PC, Yan A, Teepen JC, Morton LM. Subsequent Primary Neoplasms: Risks, Risk Factors, Surveillance, and Future Research. Pediatr Clin North Am. 2020 12; 67(6):1135-1154.
-
Singh N, Anchan RK, Besser SA, Belkin MN, Cruz MD, Lee L, Yu D, Mehta N, Nguyen AB, Alenghat FJ. High sensitivity Troponin-T for prediction of adverse events in patients with COVID-19. Biomarkers. 2020 Dec; 25(8):626-633.
-
Van Pelt A, Glick HA, Yang W, Rubin D, Feldman M, Kimmel SE. Evaluation of COVID-19 Testing Strategies for Repopulating College and University Campuses: A Decision Tree Analysis. J Adolesc Health. 2021 01; 68(1):28-34.
-
Goldstein DA, Ratain MJ, Saltz LB. Weight-Based Dosing of Pembrolizumab Every 6 Weeks in the Time of COVID-19. JAMA Oncol. 2020 11 01; 6(11):1694-1695.
-
Walker GN, Dekker AM, Hampton DA, Akhetuamhen A, Moore PQ. A Case for Risk Stratification in Survivors of Firearm and Interpersonal Violence in the Urban Environment. West J Emerg Med. 2020 Oct 16; 21(6):132-140.
-
Melmed GY, Rubin DT, McGovern DPB. Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic. Gastroenterology. 2021 02; 160(3):639-644.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|